/Companies

PathwaysGI

Ann Arbor, US · Founded 2022 · Delaware corporation

Find your way into PathwaysGI

Sign up to see every warm intro you have to PathwaysGI

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the PathwaysGI team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Pathways GI develops AI-based methods for clinical decision support in gastroenterology, with a focus on inflammatory bowel disease (IBD). The company applies computational medicine and clinical trial design expertise to healthcare applications.

Founders & leadership

PathwaysGI was founded in 2022 by Ryan Stidham and Kayvan Najarian.

RSRyan Stidham
Ryan StidhamCMO / Co-Founder
KNKayvan Najarian
Kayvan NajarianCo-Founder
KWKevin Wittrup
Kevin WittrupCEO & Co-FounderKevin Wittrup is co-founder and CEO of PathwaysGI, which develops AI-based clinical decision support tools for gastroenterology and inflammatory bowel disease.
PB
Prem BodagalaNamed on SEC filing
SB
Steve BollingNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$350K disclosed across 1 round · 2023

▶$350KraisedMar 2023 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan StidhamExecutive Officer, Director
  • Kevin WittrupExecutive Officer, Director
  • Prem BodagalaDirector
  • Kayvan NajarianExecutive Officer
  • Steve BollingDirector
Offering amount
$500K
Amount sold
$350K
Minimum investment
$50K
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does PathwaysGI do?
Pathways GI develops AI-based methods for clinical decision support in gastroenterology, with a focus on inflammatory bowel disease (IBD). The company applies computational medicine and clinical trial design expertise to healthcare applications.
Who founded PathwaysGI?
PathwaysGI was founded by Ryan Stidham, Kayvan Najarian in 2022.
How much funding has PathwaysGI raised?
PathwaysGI has disclosed $350K raised across 1 round.
Where is PathwaysGI headquartered?
PathwaysGI is headquartered in Ann Arbor, US.